NCT00848289Active, not recruiting
Genetic Susceptibility to Bladder Cancer
Genetic Susceptibility to Bladder Cancer: A Molecular Epidemiology Approach
Source: ClinicalTrials.gov · Last updated 16 Jul 2026
Brief summary (registry, in English)
This clinical research study will identify biologic and lifestyle factors which increase a person's risk of developing specific cancer. Researchers propose to conduct a case-control study examining interindividual differences in susceptibility to tobacco carcinogenesis as predictors of bladder cancer risk. We will measure susceptibility to tobacco carcinogenesis and this will include studies of the genetic modulation of carcinogen activation and detoxification and of chromosome sensitivity to tobacco mutagens.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 6086 (actual)
- First submitted
- 19 Feb 2009
- Start date
- 10 Feb 1998
- Primary completion date
- 1 Aug 2026
- Lead sponsor
- M.D. Anderson Cancer Center
- Diseases
- Bladder cancer, Childhood cancers
- NCT number
- NCT00848289
What you commit to
- Study type: Observational
- Participants enrolled: 6086
- From 10 Feb 1998 to the primary completion date, 1 Aug 2026
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Subject has had prior treatment with systemic chemotherapy or radiotherapy in the past 6 months.
Other illness
- Subject has been diagnosed with superficial or muscle-invasive bladder cancer more than twelve months ago.
Who the study is looking for
- Subject has a histologically confirmed diagnosis of superficial or muscle-invasive bladder cancer
- Subject is a Texas resident.
- Subject can understand English or a qualified translator is available for the interview.
- Subjects of any age, gender, or ethnicity are eligible to participate in the study.
- Subject consents to participate in the study.
Sex: All · Accepts healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Baylor College of Medicine Coordinator of this site? Confirm its status | Houston | United States | Unknown status |
| MD Anderson Cancer Center Coordinator of this site? Confirm its status | Houston | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.